|
HS Code |
914381 |
| Iupac Name | (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol |
| Molecular Formula | C15H12O6 |
| Molecular Weight | 288.25 g/mol |
| Synonyms | (-)-Epicatechin |
| Appearance | Off-white to pale buff powder |
| Melting Point | 237–239 °C |
| Solubility In Water | Slightly soluble |
| Logp | 0.6 |
| Cas Number | 490-46-0 |
| Pubchem Id | 72276 |
As an accredited (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 5 grams of (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol, with tamper-evident seal. |
| Container Loading (20′ FCL) | 20′ FCL container efficiently loads bulk (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol, ensuring safe transport. |
| Shipping | The chemical (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol is shipped in tightly sealed containers, protected from light and moisture. It is packed according to safety regulations, with appropriate labeling and documentation, and typically transported at ambient or controlled temperature, depending on stability and hazard class. |
| Storage | Store (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol in a cool, dry, and well-ventilated area, protected from light and moisture. Keep the container tightly sealed and store at 2–8°C. Avoid exposure to heat and incompatible materials such as strong oxidizers. Properly label the container and handle it using appropriate personal protective equipment. |
| Shelf Life | Shelf life: Store at -20°C, protected from light and moisture; stable for 2 years under recommended conditions in tightly sealed containers. |
|
Purity 98%: (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol with purity 98% is used in pharmaceutical formulation, where it ensures high efficacy and consistent therapeutic performance. Molecular Weight 304.27 g/mol: (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol with molecular weight 304.27 g/mol is used in drug discovery screening, where accurate dosing and predictable bioactivity are achieved. Melting Point 220°C: (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol with melting point 220°C is used in solid-state pharmaceutical preparations, where improved shelf stability is provided. Particle Size <10 μm: (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol with particle size <10 μm is used in nanoformulations, where it enhances dissolution rate and bioavailability. Stability Temperature up to 80°C: (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol with stability temperature up to 80°C is used in heat-stressed storage environments, where degradation is minimized. Water Solubility <0.1 mg/mL: (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol with water solubility <0.1 mg/mL is used in hydrophobic matrix encapsulation, where controlled release characteristics are achieved. |
Competitive (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Long before a shipment leaves our plant, knowledge and supervision guide every step through the intricate chemistry of (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol. Audits, hands-on monitoring, and feedback keep our technicians sharp, reminding us that delivering a consistent molecule means more than routine checks—it means understanding the quirks of every stage. Production crews at our site have learned that each batch presents its own lessons: minor adjustments in solvent ratios, changes in temperature profiles, subtle tweaks in stirring speed. Years ago, minor deviations nearly cost us an entire week’s run, so we do not skip steps; our team stresses process data logging and cross-verification. Those who only move boxes rarely see this attention to detail. For us, each batch is more than tonnage; it’s the result of countless calibrations and near-perpetual troubleshooting, not just a string of purity figures.
We do not rely on generic numbers. Our specification sheets read like a record of lab achievement rather than a copy of reference texts. Laboratories shoot for high HPLC purity—at least 98%—because in downstream applications, even a single contaminant can introduce noise or unexpected reactivity. Melt point ranges, colour profiles, and loss-on-drying data all stem from practical trial, not armchair theorizing. Our chemists understand analytical drift and recall the months spent correlating spectral signatures with batch yields. Preparation for customer audits means demonstrations of proficiency—pulling real vials, explaining raw data, and showing documentation of validated methods. The certificate handed over reflects cumulative hours, not just a summary table. This approach comes from seeing what slight deviations invite: downstream crystallization headaches, darkening due to trace metal contamination, or unstable storage profiles. We never rely on yesterday’s standards without questioning them again; our QC manager’s door rarely stays closed.
People ask what (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol does. Given our direct communication channel with buyers, we know exactly where new challenges emerge. Our product’s backbone appears in dozens of research projects, sometimes as a structural analog or as a reference in oxidative stress pathways. Synthetic biologists and medicinal chemists turn to our staff when their libraries outgrow older scaffolds. Research groups share feedback on yield, solubility, and side-reactions; every synthesis run gets a written report—there’s no such thing here as information hoarding. For antioxidant studies, our batches get requests for additional antioxidant activity screening—tests that dig deeper than standardized DPPH or ABTS methodologies. Pharmaceutical partners have shown interest, especially where chirality plays a role in molecular docking or bioavailability. We’ve learned this lesson in collaboration: close connections between bench and plant save time and amplify trust. The demand for multi-gram and kilogram scales gives us a unique view into how researchers translate bench chemistry into real-world processes.
Collective memory guides much of our design and process improvement. We use pilot-scale failures as case studies in weekly meetings, and even the oldest operators quote their own mishaps so newer technicians avoid similar pitfalls. Solubility, filtration rates, and drying steps deviate from older flavonoids—the ortho-dihydroxy groups bring oxidation risks not always taught in textbooks. Observing oxidation at the filtration stage led us to adopt a protective inert gas blanket for certain steps. Unlike traders, who only know the outside of a drum, our manufacturing teams see the inside every day—the sediment, the color drift, the difference between “off-white” and “pale yellow.” GMP auditors ask for reproducibility and traceability, but we ask how to make our process less fragile, bit by bit. From process chemists to cleaning crews, every worker gets trained to recognize what isn’t supposed to be in the mix, because experience beats blind repetition every time.
Our approach to “model” isn’t about numbers and letters—it’s about matching what various sectors need. We developed multiple run protocols to give buyers options in particle size, hydrates, and preferred counterions. For particular customers, requests push us to develop “ultra-pure” forms for trace impurity studies or to change batch sizes mid-stream. This feedback loop means ongoing investments in our reactor fleet, not just the lab. Many of the requests start with minor inquiries—an extra filtration, a request for a less hygroscopic form—which then become part of our regular product cycle if data supports it. For laboratories exploring SAR (structure-activity relationships), we provide reference samples with batch records and documented impurity profiles. Our practical record means customers do not have to guess whether a kilo from month to month behaves differently. For scale-up projects, researchers have let us in on their protocols, giving us a real window into their world, so we can plan predictability for their next step.
Those who have handled multiple flavonoids, chalcones, and catechols notice instantly how (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol stands out. Its chiral specificity brings both benefits and challenges: synthetic workload increases, and each step influences chiral purity. Standard dihydroflavonols sometimes come with broad melting ranges and powdery textures, but this one’s defined stereochemistry means a tighter profile and sharper detection in NMR and chiral HPLC. Users report higher sensitivity in biological assays—not just because of theoretical antioxidant strength, but because a single stereoisomer delivers consistent performance in test tubes and in vivo models. In food ingredient research, the additional hydroxyl groups lend reactivity not suited for every process, so stabilization requires close attention. Our technical support teams have guided customers through stabilizing solutions for difficult matrices, refusing to simply blame “degradation” on storage alone.
Our product’s nuanced structure means downstream applications—ranging from small molecule libraries to specific functional food additives—need thorough advice. We make personnel available to help design dissolution protocols and antioxidant assays, since off-the-shelf wisdom often misses steric and solubility subtleties. This stems from experience: the gap between textbook chemistry and shop-floor handling widens with each further customization. Our process chemists make themselves available—on video and in person—so customers can troubleshoot real problems, not just read generic Q&A.
Our history with this compound taught us that keeping purity above 98% takes more than basic storage. At each shipment, humidity controls and packaging protocols get reviewed. One rainy season led to surprising clumping, teaching our warehousing staff the value of layered desiccant and double-bagging. Customers sometimes ask why a product from one supplier degrades faster; we take these questions seriously. We trace handling all the way from batch reactor to packaged product, using both manual and digital logs. This vigilance comes through on receiving benches—the moment of opening drums and finding a free-flowing powder, matching what’s written on the release certificate. Tracing minor changes led us to keep a tighter rein on effluent solvent quality as well, since residuals can affect shelf life in surprising ways. We seldom claim perfection, but each improvement cycle starts from mistakes made and documented.
People want facts, not promises. We offer full analytical documentation, not only because customers ask, but because our own process improvement depends on real data. Repeat chromatogram checks form part of knowledge cycles for our workers. Spectroscopic fingerprints and impurity charts hang on lab whiteboards. Evidence-based operations keep us honest—the entire supply chain, from feedstock to drummed product, gets periodic review not to “pass audits” but to reduce risk for everyone. Researchers from academia and industry have taken samples through not just single but multi-cycle applications, reporting back stability and inter-batch consistency. This feedback matters: nearly every improvement we adopt began with a dissatisfied researcher, not a pat on the back. Unlike trader intermediaries, we remain visible to the end users, not just on invoices but on video calls, in site visits, and through data packages. Direct ties with study authors sometimes lead to pre-publication insight, so our plants anticipate changes rather than guess them.
No manufacturing plant stands still; ours least of all. We run quarterly workshops not just for compliance but to tune up our entire process—raw material selection, in-process controls, waste treatment. Every machine operator sees feedback come full circle; clear change logs track which shifts did what. Open talk between synthesis teams and support staff helps streamline bottlenecks faster than top-down directives. Smart operators keep lists of “hidden” problems—minor foaming, troublesome filtrate color, or odd odors during drying—so no issue festers unseen. New ideas come from the bench, cross-checked with batch logs and confirmed by the analytical chemists. There’s little room for arrogance or secrecy in this business; open mistakes push us forward more than closed successes.
Our leadership in manufacturing comes from relentless adherence to recognized chemical manufacturing principles, but also from taking regulation as a baseline, not the ceiling. Plants outside North America and Europe sometimes cut safety corners; we don’t. Visitors have seen our exhaust handling, hard-piped solvent circulation, and staff wearing PPE appropriate to every process stage. These habits, built from daily risk assessments, reflect years of learning from incidents—both our own and from case histories provided by industry groups. Documentation reflects open reality, not sanitized summaries; batch numbers track all the way to raw chemical origins. This is how trust gets built, batch by batch, week by week. Independent auditors point out strengths, but our own teams supply the most meaningful day-to-day oversight. Our reputation emerges from letting anyone—regulators, collaborators, researchers—examine our process with open books, not guided tours.
Manufacturing (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol means seeing how small changes ripple through production. We handle related flavonoids and observe differences in synthesis windows, ambient stability, and post-synthesis handling. With this product, the dihydroxyphenyl moiety presents more pathways for side-by-product formation; this pushes us to over-invest in purification steps, using finer filtrates, more frequent column changes, and stricter environmental control. Our yield may not match higher-volume, less-specific compounds, but reliability takes precedence.
Markets respond to stability, so our export batches go through cycles designed for distance—cool value chain storage and confirmed packaging for both small and large-volume shipments. We see the results: fewer customer complaints, lower returned materials, and more repeat orders. Quality assurance teams know precisely where issues crop up, thanks to our open reporting ecosystem. The comparison with less specific analogs finds root in these details—those who try both side by side report clearer assay results and sharper, more reliable downstream synthesis, which feeds our understanding for future optimization.
Our product knowledge results from continuous direct exposure. Plant managers and chemists stay on site, not in distant headquarters. Decisions reflect practical knowledge—the pungent odor of a fresh batch, the tactility of partially dried product, the look of a crystalline fraction under the right light. This immediate proximity matters. The broader chemical industry’s shift toward outsourcing may cut costs for some, but it subtracts from material understanding. Our approach keeps experts embedded where they do the most good: at the source, where chemistry and logistics collide. We think a better product grows from people who see its lifecycle firsthand, not just from what journals and presentations convey.
Lab-based insight remains foundational, but real-world data from customers completes the picture. Several months ago, one customer investigating food preservation observed inconsistent coloration in shelf-storage. Their sample, handled alongside competitive material, pointed us to previously unnoticed trace instability. Direct calls, not just email questionnaires, led us to launch additional forced-degradation tests. We identified a vulnerable reactive site, then changed our packaging approach. Explaining these cycles to end users encourages collaboration beyond simple sales; researchers learn that technical feedback loops shorten innovation delays. Regular follow-up, not sporadic outreach, turns challenge into incremental improvement. This culture developed organically, reinforced by seeing measurable results every time we closed a feedback loop together.
Problems arrive whether we want them or not. We step into the lab with solutions in mind, grounded in experience. If a batch unexpectedly darkens, we consult both historical records and process logs, not instincts alone. Systematic sampling uncovers issues, which sometimes require new solvent systems, pH adjustment, or re-tooling of downstream drying procedures. In handling, moisture always threatens hydrolysis or aggregation—so our plant operators custom-fit moisture controls depending on weather and season. Our team never strips batch runs from context; they read between serial numbers and watch for trends over quarters, not just single incidents.
In application, we advise customers on concentration windows, launching test runs before full-scale adoption. Each inquiry—whether about reactor fouling, poor dissolution, or color drift—pushes us to refresh our directions. Partnerships with downstream users help clarify where substitutes cannot match our purity or bench-tested stability. Our troubleshooting strategies become more robust because customers share both failures and surprise successes, making each improvement easier to scale across the plant. Small upgrades, repeated over time, separate reliable suppliers from commodity providers.
We rely on transparency, shared learning, and direct engagement to build lasting relationships with customers and industry peers. Documentation flows openly from plant to client—no walled-off data, no skipped steps. This approach costs more time but saves future trouble. Repeat business comes from delivering not just a product but honest troubleshooting, real data, and commitment. No batch leaves this facility without visible, traceable results. Staff cross-train to spot issues beyond their main job; everyone from R&D leader to night-shift operator brings a piece of the puzzle. From certificate to application, every gram owes its value to this collective knowledge.
Scientific curiosity and industrial progress do not rest. Our manufacturing methods keep pace only by welcoming complexity and uncertainty. We keep refining, questioning, and incorporating both technical advancement and regulatory progress at every level. Users bring new uses and studies to our attention; regulatory environments shift, and our control protocols shift with them. We accept that manufacturing stays dynamic and that no process remains “final” for long.
The journey behind (2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol reflects decades of disciplined risk-taking, real setbacks, and shared wins. From reactor assembly to bench-top collaboration, every step rests on what came before—experience, care, and a refusal to accept average. As more researchers, formulation experts, and industry partners push science forward, our job is to stay out ahead—not by guessing future demand, but by keeping our attention on honest practice, rigorous learning, and open dialogue.